. Author manuscript; available in PMC: 2013 Sep 1.

Published in final edited form as: J Burn Care Res. 2012 Sep-Oct;33(5):561–576. doi: 10.1097/BCR.0b013e318247eb06

Table 2. Blood Group and Immunological Status of the first full face transplant performed in Barcelona, Spain.

	Donor	Recipient
Blood Group	O−	AB+
CMV	+	−
Epstein Barr	+	+
Varicella-Zoster	+	+
Herpes Virus 1	+	−
Rubella	+	+
Toxoplasma Gondii	−	−
Treponema pallidum	−	−
Parotiditis	−	+
HIV, Hepatitis B,C	−	−
HLA	A11, A31, B35, B51 DRB 04, DRB 16	A2, B15, B57, DRB 07, DRB 12

From [72]: Barret JP, Gavalda J, Bueno J, et al. Full face transplant: the first case report. Ann Surg 2011; 254(2): 252-6.

Legend: Recipient infections after all the FCTAs till now performed have involved cytomegalovirus (CMV), herpes simplex virus-1 (HSV-1) and Epstein-Barr virus (EBV). Antiviral treatment to prevent CMV and HSV-1 for at least 3 months post-transplantation is strongly recommended [26].